With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption Medical Dialogues Bureau21 Nov 2019 12:09 PM ISTNew Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide Farhat Nasim10 Aug 2019 4:51 PM ISTNEW DELHI: In a bid to re-enter the market with advanced drug-eluting stents (DES), various medical device makers are in talks with the Government to...
Meril Life Sciences gets European Conformity mark for Bioresorbable Scaffold MeRes100 Medical Dialogues Bureau9 Aug 2019 9:45 AM ISTMeril Life Sciences MeRes100 has received both Drug Controller General of India(DCGI) and CE (European Conformity) marketing approval. New Delhi:...
Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent Meghna A Singhania5 March 2019 5:01 PM ISTNew Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent Meghna A Singhania3 Feb 2019 11:16 AM ISTNew Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
Cannot exceed 8 percent trade margin on Stents: NPPA Ruby Khatun Khatun4 Aug 2017 6:00 PM ISTNew Delhi: NPPA has taken a step ahead to prevent distributors from grabbing higher profits and manipulating trade margins on coronary stents than the...
After Abbott, two more Stent makers seek withdrawal of New Gen Stents Ruby Khatun Khatun24 April 2017 1:39 PM ISTMUMBAI: Soon after Abbott was seen seeking withdrawal of its withdraw two types of stents from the Indian market, reports are coming in that two more...
